Takeda to buy Nycomed for $13.6 billion

some delays, it won U.S. approval in March where Forest Laboratories has the marketing rights. In Europe, Merck & Co. has marketing rights. Takeda has also unsuccessfully explored takeovers of other European drugmakers previously, including Organon and...